<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPTR64028</article-id>
      <title-group>
        <article-title>Preparation, Evaluation and Optimization of In-situ gel of Fluoxetine HCl for Intranasal drug delivery</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Tripathi</surname>
            <given-names>Sapna</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mukhopadhyay</surname>
            <given-names>Sayantan</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kothiyal</surname>
            <given-names>Preeti</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2016-08-01">
        <month>08</month>
        <day>01</day>
        <year>2016</year>
      </pub-date>
      <volume>6</volume>
      <issue>4</issue>
      <abstract>
        <p>In-situ gelling system is a process in which a solution form converted into the gel form after the formulation has been applied at the site. In-situ gel is helpful to produce sustained release of drug. Fluoxetine HCl is a selective serotonin reuptake inhibitor. The current study deals with the preparation, evaluation and optimization of In-situ gel of Fluoxetine HCl for intranasal delivery for the effective treatment of depression. The In-situ gel of Fluxetine HCl was prepared by cold-technique and evaluated for its physical appearance, viscosity, Gel forming temperature, Melting temperature, pH, Spreadability, Swelling index, Drug content and In-vitro release study. In-vitro drug release for optimized formulation was found to be 95.55% of F2 and pH, Drug content, Spreadability, Gelling temperature, Melting temperature were found to be 6.3, 97.6%, 8.0 gmcm/sec, 330C, 790C respectively. The study clearly demonstrated that the Fluoxetine HCl can be successfully delivered through nasal route by preparing in-situ gel. Gel is non-irritating when delivered through nasal route.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Intransal delivery</kwd>
        <kwd>Fluoxetine HCl</kwd>
        <kwd>In-situ nasal gel</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
